Clinical Trials
Clinical Trial Automation Advent Fuels Sustainable Pharma
The pharmaceutical sector is looking for certain transformative strategies so as to stay ahead in an era that is marked by fast technological growth as well as increasing stress when it comes to environmental consciousness. This endeavor has led...
Clinical Trials
Therapeutic Market Eyeing Better Access With Digi Innovation
Right from finding potential active substances as well as identifying novel targets to simulating how drugs will perform within the human body and also optimizing laboratory workflows, digital technologies are creating a massive impact when it comes to drug...
Clinical Trials
Long-Term Findings of CAR-NK Cell Therapy Look Promising
In a recent development, researchers from the US have gone on to report some promising outcomes out of a Phase I/II trial when it comes to cancer patients who get treated due to cord blood-led CD19-targeted chimeric antigen receptor-CAR...
Clinical Trials
Distinguished Clinical Programmer Swaruparani Kolla Surpasses Decade of Outstanding Contributions in Clinical Trials
Principal Clinical SAS Programmer Swaruparani Kolla recently marked her 11-year anniversary of critical contributions in clinical trial data highlighted by years of increasing responsibilities in some of the world’s largest CROs and pharmaceutical companies. She leads a team of...
Clinical Trials
Permanent Manufacturer Authorization For Vetter, Rankweil
Vetter, which happens to be a global CDMO, has gone on to receive permanent manufacturer authorization as far as its clinical development site in Rankweil, Austria, is concerned.
Functional for almost a couple of years, the responsible national regulatory authority,...
Clinical Trials
Future Clinical Trials Bill To Help Regulating Trials In UK
The Policy Exchange has come up with a report that highlights the potential benefits of The Future Clinical Trials Bill when it comes to improving UK's approach in case of establishing and regulating clinical trials.
The new bill is one of...
Clinical Trials
MHRA Rolls Out New Scheme For Lowest-Risk UK Clinical Trials
The Medicines and Healthcare products Regulatory Agency has gone on to launch a new scheme that seeks to lessen the nod time when it comes to clinical trials in the UK that are at lowest risk by more than 50%.Â
The novel...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read